Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission (2017)

  • Authors:
  • USP affiliated authors: BARBOSA, MARCELLO HENRIQUE NOGUEIRA - FMRP ; SALMON, CARLOS ERNESTO GARRIDO - FFCLRP ; PAULA, FRANCISCO JOSE ALBUQUERQUE DE - FMRP ; TRONCON, LUIZ ERNESTO DE ALMEIDA - FMRP
  • USP Schools: FMRP; FFCLRP; FMRP; FMRP
  • DOI: 10.1007/s00198-017-4014-3
  • Subjects: DENSIDADE ÓSSEA; ESTUDOS DE CASOS E CONTROLES; COLITE ULCERATIVA; DOENÇA DE CROHN; ENTEROPATIAS; RESSONÂNCIA MAGNÉTICA; OSTEOPOROSE
  • Keywords: Bone marrow adipose tissue; Bone mass; Crohn’s disease; Inflammatory bowel diseases; Ulcerative colitis
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00198-017-4014-3 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BASTOS, C. M.; ARAÚJO, Iana Mizumukai de; NOGUEIRA-BARBOSA, Marcello Henrique; et al. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission. Osteoporosis International, London, v. 28, n. 7, p. 2167-2176, 2017. Disponível em: < http://dx.doi.org/10.1007/s00198-017-4014-3 > DOI: 10.1007/s00198-017-4014-3.
    • APA

      Bastos, C. M., Araújo, I. M. de, Nogueira-Barbosa, M. H., Salmon, C. E. G., Paula, F. J. A. de, & Troncon, L. E. de A. (2017). Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission. Osteoporosis International, 28( 7), 2167-2176. doi:10.1007/s00198-017-4014-3
    • NLM

      Bastos CM, Araújo IM de, Nogueira-Barbosa MH, Salmon CEG, Paula FJA de, Troncon LE de A. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission [Internet]. Osteoporosis International. 2017 ; 28( 7): 2167-2176.Available from: http://dx.doi.org/10.1007/s00198-017-4014-3
    • Vancouver

      Bastos CM, Araújo IM de, Nogueira-Barbosa MH, Salmon CEG, Paula FJA de, Troncon LE de A. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission [Internet]. Osteoporosis International. 2017 ; 28( 7): 2167-2176.Available from: http://dx.doi.org/10.1007/s00198-017-4014-3

    Referências citadas na obra
    Ali T, Lam D, Bronze MS et al (2009) Osteoporosis in inflammatory bowel disease. Am J Med 122:599–604
    Ghosh S, Cowen S, Hannan WJ et al (1994) Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 107:1031–1039
    Tilg H, Moschen AR, Kaser A et al (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57:684–694
    Jahnsen J, Falch JA, Aadland E et al (1997) Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population based study. Gut 40:313–319
    Ardizzone S, Bollani S, Bettica P et al (2000) Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis. J Intern Med 247:63–70
    Silvennoinen A, Karttunen TJ, Niemelã SE et al (1995) A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 37:71–76
    Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4:368–381
    Pigot F, Roux C, Chaussade S et al (1992) Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 37:1396–1403
    Roux C, Abitbol V, Chaussade S et al (1995) Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 5:156–160
    Targownik LE, Bernstein CN, Leslie WD (2014) Risk factors and management of osteoporosis in inflammatory bowel disease. Curr Opin Gastroenterol 30:168–174
    Pietschmann P, Resch H, Woloszczuk W et al (1990) A circadian rhythm of serum osteocalcin levels in postmenopausal osteoporosis. Eur J Clin Investig 20:310–312
    Yavropoulou MP, Tomos K, Tsekmekidou X et al (2011) Response of biochemical markers of bone turnover to oral glucose load in diseases that affect bone metabolism. Eur J Endocrinol 164:1035–1041
    Sanchez Cano D, Ruiz-Villaverde R, Olvera Porcel MC et al (2011) Evaluation of bone mineral density, bone turnover markers, the OPG/RANKL system and sTNF-RI in Crohn’s disease. Gastroenterol Hepatol 34:3–9
    de Paula FJ, Rosen CJ (2013) Bone remodeling and energy metabolism: new perspectives. Bone Res 1:72–84
    Bianco P, Riminucci M, Gronthos S et al (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180–192
    Li X, Kuo D, Schafer AL et al (2011) Quantification of vertebral bone marrow fat content using 3 tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging 33:974–979
    Bredella MA, Fazeli PK, Miller KK et al (2009) Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 94:2129–2136
    Liu Y, Tang GY, Tang RB et al (2010) Assessment of bone marrow changes in postmenopausal women with varying bone densities: magnetic resonance spectroscopy and diffusion magnetic resonance imaging. Chin Med J 123:1524–1527
    Tang GY, Lv ZW, Tang RB et al (2010) Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Radiol 65:377–381
    Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5a–36a
    Best WR, Becktel JM, Singleton JW et al (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444
    Schousboe JT, Shepherd JA, Bilezikian JP et al (2013) Executive summary of the 2013 ISCD position development conference on bone densitometry. J Clin Densitom 16:455–467
    de Paula FJA, de Araújo IM, Carvalho AL et al (2015) The relationship of fat distribution and insulin resistance with lumbar spine bone mass in women. PLoS One 10:e0129764
    Zhang Q, Riddle RC, Clemens TL (2015) Bone and the regulation of global energy balance. J Intern Med 277:681–689
    Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35–43
    Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381
    van Hogezand RA, Hamdy NA (2006) Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl 243:59–64
    Bernstein CN, Leslie WD, Leboff MS (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124:795–841
    Compston J, Reid DM, Boisdron J et al (2008) Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science. Osteoporos Int 19:1247–1250
    Seguro LP, Rosario C, Shoenfeld Y (2013) Long-term complications of past glucocorticoid use. Autoimmun Rev 12:629–632
    Cohen A, Shen W, Dempster DW et al (2015) Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy (1H-MRS) at the spine but not the femur. Osteoporos Int 26:2471–2478
    Bredella MA, Daley SM, Kalra MK et al (2015) Marrow adipose tissue quantification of the lumbar spine by using dual-energy CT and single-voxel 1H MR spectroscopy: a feasibility study. Radiology 277:230–235
    Maciel JG, de Araújo IM, Carvalho AL et al (2016) Marrow fat quality differences by sex in healthy adults. J Clin Densitom. doi: 10.1016/j.jocd.2016.08.002
    Blebea JS, Houseni M, Torigian DA et al (2007) Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl Med 37:185–194
    Liney GP, Bernard CP, Manton DJ et al (2007) Age, gender, and skeletal variation in bone marrow composition: a preliminary study at 3.0 tesla. J Magn Reson Imaging 26:787–793
    Schwartz AV (2015) Marrow fat and bone: review of clinical findings. Front Endocrinol 6:1–6
    Devlin MJ, Cloutier AM, Thomas NA et al (2010) Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res 25:2078–2088
    Fazeli PK, Bredella MA, Freedman L et al (2012) Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res 27:1864–1871
    de Araújo IM, Salmon CE, Nahas AK et al (2017) Marrow adipose tissue spectrum in obesity and type 2 diabetes mellitus. Eur J Endocrinol 176:21–30
    Schett G, Kiechl S, Redlich K et al (2004) Soluble RANKL and risk of nontraumatic fracture. JAMA 291:1108–1113
    Vega D, Maalouf NM, Sakhaee K (2007) CLINICAL review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 92:4514–4521
    Cawthorn WP, Scheller EL, Leaman BS et al (2014) Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab 20:368–375
    Pironi L, Callegari C, Cornia GL et al (1988) Lactose malabsorption in adult patients with Crohn’s disease. Am J Gastroenterol 83:1267–1271
    Dinca M, Fries W, Luisetto G et al (1999) Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 94:1292–1297
    Arj A, Razavi Zade M, Yavari M et al (2016) Proton pump inhibitors use and change in bone mineral density. Int J Rheum Dis 19:864–868